Sarah Boyce
CIK 1629383 · Lihat di SEC EDGAR ↗
Pengajuan SEC Pertama: 11 Juni 2020 · Terbaru: 13 Juni 2022
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 3 Feb. 2023 | RNA | S 10b5-1 | 3.221 | $24,26 | $78.141 | 53.352 Langsung | -5,69% | Dilepas | |
| 2 Feb. 2023 | RNA | S 10b5-1 | 45.879 | $24,36 | $1.117.612 | 53.352 Langsung | -46,23% | Dilepas | |
| 1 Feb. 2023 | RNA | S 10b5-1 | 900 | $24,27 | $21.843 | 53.352 Langsung | -1,66% | Dilepas | |
| 10 Nov. 2022 | OABIW | P | 15.000 | $2,92 | $43.800 | 36.000 Tidak Langsung | +71,43% | Diakuisisi | -92,2% (harga per 2026-08-19) |
| 9 Nov. 2022 | OABIW | P | 21.000 | $2,74 | $57.540 | 21.000 Tidak Langsung | — | Diakuisisi | -91,7% (harga per 2026-08-19) |
| 25 Agu 2022 | RNA | S 10b5-1 | 14.855 | $23,07 | $342.705 | 0 Langsung | -100,00% | Dilepas | |
| 24 Agu 2022 | RNA | S 10b5-1 | 35.045 | $22,80 | $799.026 | 0 Langsung | -100,00% | Dilepas | |
| 15 Agu 2022 | RNA | S 10b5-1 | 100 | $22,47 | $2.247 | 0 Langsung | -100,00% | Dilepas | |
| 16 Jan. 2018 | IONS | S | 2.196 | $51,76 | $113.665 | 8.931 Langsung | -19,74% | Dilepas | 16,6% (harga per 2026-08-19) |
| 17 Jan. 2017 | IONS | S | 506 | $46,29 | $23.423 | 5.252 Langsung | -8,79% | Dilepas | 30,3% (harga per 2026-08-19) |
| 17 Jan. 2017 | IONS | S | 855 | $46,29 | $39.578 | 4.463 Langsung | -16,08% | Dilepas | 30,3% (harga per 2026-08-19) |
| 19 Jan. 2016 | IONS | S | 872 | $41,46 | $36.153 | 1.735 Langsung | -33,45% | Dilepas | 45,5% (harga per 2026-08-19) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 26 Juni 2026 | CTNM | Stock Option (right to buy) | Class A Common Stock (19.000) | $14,19 | 25 Juni 2036 | 19.000 | Diakuisisi |
| 27 Feb. 2026 | RNA | Stock Option (Right to Buy) | Common Stock (165.000) | $31,42 | 5 Jan. 2035 | 165.000 | Dilepas |
| 27 Feb. 2026 | RNA | Stock Option (Right to Buy) | Common Stock (300.000) | $10,16 | 19 Jan. 2034 | 300.000 | Dilepas |
| 27 Feb. 2026 | RNA | Stock Option (Right to Buy) | Common Stock (200.000) | $6,57 | 10 Sep. 2033 | 200.000 | Dilepas |
| 27 Feb. 2026 | RNA | Stock Option (Right to Buy) | Common Stock (400.000) | $22,47 | 19 Jan. 2033 | 400.000 | Dilepas |
| 27 Feb. 2026 | RNA | Stock Option (Right to Buy) | Common Stock (425.000) | $14,22 | 20 Jan. 2032 | 425.000 | Dilepas |
| 27 Feb. 2026 | RNA | Stock Option (Right to Buy) | Common Stock (300.000) | $22,34 | 1 Feb. 2031 | 300.000 | Dilepas |
| 27 Feb. 2026 | RNA | Stock Option (Right to Buy) | Common Stock (386.015) | $1,24 | 17 Des. 2029 | 386.015 | Dilepas |
| 3 Feb. 2023 | RNA | Stock Option (Right to | Common Stock (3.221) | $1,24 | 17 Des. 2029 | 3.221 | Dilepas |
| 2 Feb. 2023 | RNA | Stock Option (Right to Buy) | Common Stock (45.879) | $1,24 | 17 Des. 2029 | 45.879 | Dilepas |
| 1 Feb. 2023 | RNA | Stock Option (Right to Buy) | Common Stock (900) | $1,24 | 17 Des. 2029 | 900 | Dilepas |
| 20 Jan. 2023 | RNA | Stock Option (Right to Buy) | Common Stock (400.000) | $22,47 | 19 Jan. 2033 | 400.000 | Diakuisisi |
| 1 Nov. 2022 | OABIW | Stock Option | Common Stock (37.840) | $9,10 | 10 Juni 2032 | 37.840 | Diakuisisi |
| 1 Nov. 2022 | OABIW | Stock Option | Common Stock (13.994) | $13,24 | 4 Juni 2031 | 13.994 | Diakuisisi |
| 1 Nov. 2022 | OABIW | Stock Option | Common Stock (10.565) | $13,49 | 10 Juni 2030 | 10.565 | Diakuisisi |
| 1 Nov. 2022 | OABIW | Stock Option | Common Stock (22.616) | $12,37 | 15 Okt. 2029 | 22.616 | Diakuisisi |
| 1 Nov. 2022 | LGND | Employee Stock Option (right to buy) | Common Stock (4.340) | $90,68 | 10 Juni 2032 | 4.340 | Dilepas |
| 25 Agu 2022 | RNA | Stock Option (Right to Buy) | Common Stock (14.855) | $1,24 | 17 Des. 2029 | 14.855 | Dilepas |
| 24 Agu 2022 | RNA | Stock Option (Right to Buy) | Common Stock (35.045) | $1,24 | 17 Des. 2029 | 35.045 | Dilepas |
| 15 Agu 2022 | RNA | Stock Option (Right to Buy) | Common Stock (100) | $1,24 | 17 Des. 2029 | 100 | Dilepas |
| 10 Juni 2022 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock (4.340) | $79,29 | 10 Juni 2032 | 4.340 | Diakuisisi |
| 21 Jan. 2022 | RNA | Stock Option (Right to Buy) | Common Stock (425.000) | $14,22 | 20 Jan. 2032 | 425.000 | Diakuisisi |
| 4 Juni 2021 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock (3.269) | $115,39 | 4 Juni 2031 | 3.269 | Diakuisisi |
| 2 Feb. 2021 | RNA | Stock Option (Right to Buy) | Common Stock (300.000) | $22,34 | 1 Feb. 2031 | 300.000 | Diakuisisi |
| 10 Juni 2020 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock (2.468) | $117,58 | 10 Juni 2030 | 2.468 | Diakuisisi |
| 15 Okt. 2019 | LGND | Non-Qualified Stock Option (right to buy) | Common Stock (5.283) | $107,81 | 15 Okt. 2029 | 5.283 | Diakuisisi |
| 15 Jan. 2018 | IONS | Restricted Stock Units | Common Stock (5.367) | — | — | 5.367 | Dilepas |
| 15 Jan. 2018 | IONS | Restricted Stock Units | Common Stock (12.916) | — | — | 12.916 | Diakuisisi |
| 2 Jan. 2018 | IONS | Employee Stock Option (right to buy) | Common Stock (58.125) | $49,25 | 1 Jan. 2025 | 58.125 | Diakuisisi |
| 15 Jan. 2017 | IONS | Restricted Stock Units | Common Stock (1.295) | — | — | 1.295 | Dilepas |
| 15 Jan. 2017 | IONS | Restricted Stock Units | Common Stock (2.188) | — | — | 2.188 | Dilepas |
| 15 Jan. 2017 | IONS | Restricted Stock Units | Common Stock (7.537) | — | — | 7.537 | Diakuisisi |
| 3 Jan. 2017 | IONS | Employee Stock Option (right to buy) | Common Stock (45.225) | $47,34 | 2 Jan. 2024 | 45.225 | Diakuisisi |
| 15 Jan. 2016 | IONS | Restricted Stock Units | Common Stock (2.188) | — | — | 2.188 | Dilepas |
| 15 Jan. 2016 | IONS | Restricted Stock Units | Common Stock (5.178) | — | — | 5.178 | Diakuisisi |
| 4 Jan. 2016 | IONS | Employee Stock Option (right to buy) | Common Stock (31.070) | $61,68 | 3 Jan. 2023 | 31.070 | Diakuisisi |
| 15 Jan. 2015 | IONS | Restricted Stock Units | Common Stock (8.750) | — | — | 8.750 | Diakuisisi |
| 1 Jan. 2015 | IONS | Employee Stock Option (right to buy) | Common Stock (52.500) | $61,74 | 31 Des. 2021 | 52.500 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 2 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 11 Juni 2020 | RNA | Stock Option (Right to Buy)→ Common Stock (1.197.015) | 1.197.015 | Langsung |
| 5 Jan. 2015 | IONS | No Securities Owned | 0 | Langsung |
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
CIK 1599901
| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $659.900 | — | $10.748.480 | $2.157.090 | $594.000 | — | $17.010 | $14.176.480 |
| 2023 | $634.500 | — | $10.140.840 | — | $349.000 | — | $15.379 | $11.139.719 |
| 2022 | $601.400 | — | — | — | $430.100 | — | $15.336 | $5.366.111 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.